SBLATTERO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 3.420
EU - Europa 3.268
AS - Asia 1.967
SA - Sud America 333
Continente sconosciuto - Info sul continente non disponibili 50
AF - Africa 36
OC - Oceania 3
AN - Antartide 1
Totale 9.078
Nazione #
US - Stati Uniti d'America 3.343
RU - Federazione Russa 898
IE - Irlanda 718
SG - Singapore 562
CN - Cina 556
DE - Germania 367
SE - Svezia 351
HK - Hong Kong 334
UA - Ucraina 271
VN - Vietnam 263
BR - Brasile 250
IT - Italia 231
FI - Finlandia 174
FR - Francia 107
GB - Regno Unito 68
IN - India 64
CA - Canada 43
KR - Corea 41
AR - Argentina 37
BD - Bangladesh 26
ID - Indonesia 26
MX - Messico 24
EC - Ecuador 20
TR - Turchia 19
IR - Iran 17
BE - Belgio 15
PL - Polonia 15
ZA - Sudafrica 14
ES - Italia 13
NL - Olanda 12
JP - Giappone 10
IQ - Iraq 9
AT - Austria 8
CO - Colombia 7
PY - Paraguay 7
CZ - Repubblica Ceca 6
EU - Europa 6
PK - Pakistan 6
BJ - Benin 5
MY - Malesia 5
VE - Venezuela 5
PH - Filippine 4
RO - Romania 4
SA - Arabia Saudita 4
TN - Tunisia 4
UZ - Uzbekistan 4
AU - Australia 3
DO - Repubblica Dominicana 3
LT - Lituania 3
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
OM - Oman 2
PE - Perù 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AQ - Antartide 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GT - Guatemala 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
NI - Nicaragua 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SR - Suriname 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 9.034
Città #
Dublin 711
San Jose 519
Jacksonville 484
Hong Kong 333
Dearborn 219
Singapore 212
Beijing 207
Ashburn 159
Council Bluffs 159
Wilmington 125
Moscow 108
Chandler 106
Columbus 88
Lauterbourg 88
Lawrence 88
Los Angeles 88
Princeton 88
Ho Chi Minh City 81
Ann Arbor 80
San Mateo 75
Andover 58
Piemonte 53
Buffalo 46
Hanoi 46
Seoul 40
Dallas 39
New York 39
Santa Clara 36
Düsseldorf 32
São Paulo 30
Tianjin 18
Boardman 17
Guangzhou 17
Kunming 17
Hefei 16
Houston 16
Frankfurt am Main 15
Munich 15
Novara 15
Turin 15
Brussels 14
Da Nang 14
Monmouth Junction 14
Toronto 14
Brooklyn 13
Chennai 13
Nanjing 13
Orem 13
Helsinki 12
Philadelphia 12
Phoenix 12
Warsaw 12
Mexico City 11
Milan 11
Woodbridge 11
Denver 10
Montreal 10
Johannesburg 9
Kocaeli 9
Norwalk 9
Seattle 9
Tokyo 9
Atlanta 8
Boston 8
Bremen 8
Chicago 8
Dong Ket 8
Haiphong 8
Jakarta 8
London 8
Nuremberg 8
Shenzhen 8
Vienna 8
Fairfield 7
Hangzhou 7
Manchester 7
Quito 7
Redondo Beach 7
Rome 7
San Francisco 7
Stockholm 7
Thái Bình 7
Tornaco 7
Amsterdam 6
Ardabil 6
Biên Hòa 6
Fuzhou 6
Grafing 6
Jinan 6
Leawood 6
Mumbai 6
Nanchang 6
Naples 6
Shenyang 6
Vercelli 6
Zanjan 6
Barnet 5
Brasília 5
Can Tho 5
Cotonou 5
Totale 5.108
Nome #
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 165
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 150
Gliadin-dependent UPR induction directly triggers the expression of TG2 and pro-inflammatory cytokines, dysregulates intestinal permeability, and reduces CFTR expression in intestinal epithelial cells of celiac disease patients 148
InteractomeSeq: a web server for the identification and profiling of domains and epitopes from phage display and next generation sequencing data 148
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo 148
A non-hypothesis-driven practical laboratory activity on functional metagenomics: “fishing” protein-coding DNA sequences from microbiomes 145
A reliable screening procedure for coeliac disease in clinical practice 144
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 140
A definitive set of oligonucleotide primers for amplifying human V regions 137
An Air-well sparging minifermenter system for high-throughput protein production. 136
RECOMBINANT ANTIBODIES AGAINST HUMAN TYPE II TRANSGLUTAMINASE AND USES THEREOF 134
The RNA-binding protein ILF3 binds to transposable element sequences in SINEUP lncRNAs 133
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ 130
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 130
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 123
Antibodies in proteomics I: generating antibodies 123
High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids 122
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 120
A deep-blue OLED-based biochip for protein microarray fluorescence detection. 119
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 118
Antibody library selection by the beta-lactamase protein fragment complementation assay 117
Dpp10 - A New Putative Regulatory ß-subunit Of Ito In Failing And Non-failing Human Heart 116
Identification of novel proteins binding the AU-rich element of α-prothymosin mRNA through the selection of open reading frames (RIDome) 115
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 113
Recombinant antibodies against CD55 and CD59 and uses thereof 113
Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors 111
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of I (to) channel complex 111
Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis 111
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 109
The CXCR3/PLC/IP3-IP3R axis is responsible for the ignition of UPR in intestinal epithelial cells exposed to gliadin peptide, during the onset of celiac disease 109
Autoantibodies as predictors of disease 108
A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. 108
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 108
Anti transglutaminase antibodies cause ataxia in mice 103
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 102
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 101
An albumin-derived peptide scaffold capable of binding and catalysis. 101
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 101
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 101
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 100
Profiling the autoantibody repertoire by screening phage-displayed human cDNA libraries 98
Plasmid incompatibility: more compatible than previously thought? 98
Deglycosylation effects of tunicamycin and neuraminidase on Kv4.3 channel complex 97
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives 96
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 96
Anti-transglutaminase antibodies and age 93
Recombinant antibodies against CD55 and CD59 and uses thereof 93
Treatment of arthritis models by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 92
Role of the C-terminal fragment of osteopontin in multiple sclerosis 92
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 90
Anti-idiotypic response in mice expressing human autoantibodies 90
Phage display technology for human monoclonal antibodies 90
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 89
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 89
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 89
Profiling celiac disease antibody repertoire. 89
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease 88
The transmembrane beta-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current Ito 88
Simple scale-up of recombinant antibody production using an UCOE containing vector 88
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor 87
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells. 87
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 87
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. 86
Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies 84
Binders based on dimerised immunoglobulin VH domains 83
The gut as site of production of autoimmune antibodies 83
Predicting antigenic peptides suitable for the selection of phage antibodies 83
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 83
Exploiting recombination in single bacteria to make large phage antibody libraries 80
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease 80
Primer sets for cloning the human repertoire of T cell Receptor Variable regions 79
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 78
Characterizing monoclonal antibody epitopes by filtered gene fragment phage display 77
Method for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof 76
Mass screening for coeliac disease using antihuman transglutaminase antibody assay 75
Rapid interactome profiling by massive sequencing 75
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 75
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine 72
Selecting open reading frames from DNA 71
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics. 71
Defining the Helicobacter pylori Disease-Specific Antigenic Repertoire 70
Testing for anti-human transglutaminase antibodies in saliva is not useful for diagnosis of celiac disease 69
Mucosal tissue transglutaminase expression in celiac disease 69
Characterization of the Anti-Tissue Transglutaminase Antibody Response in Nonobese Diabetic Mice 68
Dual sugar gut-permeability testing on blood drop in animal models 68
Development of a novel rapid non-invasive screening test for coeliac disease 67
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5. 67
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 66
Selection and characterization of a novel agonistic human recombinant anti-TRAIL_R2 minibody with anti_leukemic activity 66
Gluten ataxia: passive transfer in a mouse model 63
Using archaeal histones for precise DNA fragmentation 61
Cryptic gluten intolerance in type 1 diabetes: identifying suitable candidates for a gluten free diet 56
Totale 9.078
Categoria #
all - tutte 45.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022571 0 0 108 79 33 2 65 17 44 40 66 117
2022/20231.227 94 44 68 28 43 111 22 66 699 3 31 18
2023/2024298 29 14 22 8 61 5 72 5 0 1 24 57
2024/2025867 10 3 28 6 18 47 117 47 262 135 33 161
2025/20263.569 125 190 400 545 271 188 599 540 242 313 119 37
2026/2027537 90 325 122 0 0 0 0 0 0 0 0 0
Totale 9.078